News Focus
News Focus
icon url

HappyLibrarian

10/19/22 7:08 AM

#523063 RE: meirluc #523033

Most investors go off of summaries since they are not new scientists and this is especially true for new investors and potential investors.

Right now here is a top result for NWBO on Google:

https://seekingalpha.com/article/4547170-northwest-biotherapeutics-biopharmas-promising-delinquent

When NWBO does not effectively communicate this is what people read. They’re not coming on here to get both sides.

So if one wants NWBO to get a good image and argue that gas to wait on the journal article then that is an argument one still maker albeit a weaker one with each passing week.

What I am saying is that Adam Feuerstein can and will control the narrative if NWBO management does not prove by deeds that they have learned from the last two major clashes with him (Buzdargate and NYAS).

That is a reasonable point and not even an anti-management point but basically just the fact of the matter.